iBio, Inc. announced that on January 11, 2023, Mr. Robert Lutz, the Chief Financial and Business Officer of the company provided the Company notice of his resignation as an executive officer of the Company, effective February 10, 2023. Mr. Lutz informed the Company that he was resigning from the Company as an executive officer to pursue another opportunity and that his resignation from the Company was not the result of any disagreement relating to the Company's strategy, operations, policies or practices or any issues regarding the Company's accounting policies, procedures, estimates or judgements.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | -3.72% | -3.72% | +32.12% |
1st Jan change | Capi. | |
---|---|---|
+32.12% | 16.19M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- IBIO Stock
- News iBio, Inc.
- IBio, Inc. Announces Resignation of Robert Lutz, the Chief Financial and Business Officer as an Executive Officer, Effective February 10, 2023